FDA’s Office of Global Policy and Strategy holds a unique role in helping to advance and safeguard Americans by way of ensuring global considerations are fully integrated into FDA’s policies and operational activities. In a uniform fashion, the Office of Global Policy and Strategy seeks to achieve this through the mutual reinforcement of policy coherence, the strengthening of global partnerships, and the collection, analysis, and disseminating of high-quality information. Within a similar fold, the Office of Global Policy and Strategy works to enhance the breadth of international policy and diplomacy as well as compliance efforts taking place on the front-lines, both domestically and aboard, in order to maintain regulatory symmetry while also mitigating issues as they arise. It’s the hope that with these objectives working in tandem together that our office is able to continue to protect and promote public health to the fullest extent possible.
OGPS is comprised of three sub-offices: The Office of Global Operations (OGO), which includes our foreign posts, the Office of Global Diplomacy and Partnerships (OGDP), and the Office of Trade, Mutual Recognition, and International Arrangements (OTMRIA).
Each FDA-TRACK program area collects, analyzes, and reports its performance measures and results. Explore the progress OGPS is making to protect public health below: